Guzy neuroendokrynne – Zapobieganie i profilaktyka

Guzy neuroendokrynne
Zapobieganie i profilaktyka

Guzy neuroendokrynne (NET) to nowotwory wywodzące się z komórek neuroendokrynnych, często produkujące nadmierne ilości hormonów, co wpływa na układ nerwowy. Etiologia NET pozostaje niejasna, a kontrolowalne czynniki ryzyka nie są znane, co utrudnia profilaktykę. W przypadku guzów neuroendokrynnych trzustki (pNET) palenie tytoniu jest możliwym czynnikiem ryzyka, a nadmierne spożycie alkoholu może pośrednio zwiększać ryzyko poprzez przewlekłe zapalenie trzustki. Rodzinna historia nowotworów i zespoły genetyczne, takie jak MEN, zwiększają ryzyko rozwoju NET, co wymaga konsultacji lekarskiej i ewentualnych badań genetycznych. Zalecenia profilaktyczne obejmują unikanie tytoniu, ograniczenie alkoholu, utrzymanie BMI <25, regularną aktywność fizyczną oraz dietę bogatą w owoce i warzywa, a ubogą w przetworzone mięso.

Profilaktyka guzów neuroendokrynnych

Guzy neuroendokrynne (NET) stanowią grupę nowotworów wywodzących się z komórek neuroendokrynnych, które wykazują podobieństwo do komórek nerwowych i komórek produkujących hormony. Te nowotwory często wytwarzają nieprawidłowe ilości hormonów, co wpływa na funkcjonowanie układu nerwowego.¹ Mimo rosnącej częstości występowania guzów neuroendokrynnych na całym świecie, dokładna etiologia tych nowotworów pozostaje niejasna, co utrudnia opracowanie konkretnych strategii zapobiegawczych.²³

Czynniki ryzyka i możliwości zapobiegania

Obecnie nie są znane kontrolowalne czynniki ryzyka dla guzów neuroendokrynnych, co oznacza, że nie istnieje skuteczna metoda całkowitego zapobiegania ich rozwojowi.⁴⁵ Podobnie jak w przypadku innych nowotworów, pewne modyfikacje stylu życia mogą pomóc w ogólnym zmniejszeniu ryzyka zachorowania na nowotwory, w tym potencjalnie na guzy neuroendokrynne:

Unikanie wyrobów tytoniowych – tytoń jest powiązany z wieloma nowotworami i odpowiada za 90% zgonów z powodu raka płuc⁶⁷
Ograniczenie spożycia alkoholu – nawet umiarkowane spożycie alkoholu może zwiększać ryzyko nowotworów jelita grubego, piersi, przełyku i jamy ustno-gardłowej⁸⁹
Utrzymywanie prawidłowej masy ciała (np. wskaźnika masy ciała poniżej 25)¹⁰
Regularna aktywność fizyczna – brak aktywności fizycznej zwiększa ryzyko wielu nowotworów¹¹¹²
Dieta bogata w owoce i warzywa, a uboga w przetworzone mięso¹³

W przypadku guzów neuroendokrynnych trzustki (pNET), palenie tytoniu zostało zidentyfikowane jako możliwy do uniknięcia czynnik ryzyka. Rzucenie palenia może pomóc w obniżeniu tego ryzyka.¹⁴ Choć związek między nadmiernym spożyciem alkoholu a pNET nie został jednoznacznie udowodniony, nadmierne spożycie alkoholu może prowadzić do stanów takich jak przewlekłe zapalenie trzustki, które wiąże się ze zwiększonym ryzykiem pNET.¹⁵

Znaczenie wiedzy o historii rodzinnej

Istotne jest poznanie rodzinnej historii chorób nowotworowych i omówienie jej z lekarzem. Niektóre zespoły genetyczne, jak wielogruczolakowatość wewnątrzwydzielnicza (MEN), mogą zwiększać ryzyko rozwoju guzów neuroendokrynnych.¹⁶ Osoby z podwyższonym ryzykiem guzów neuroendokrynnych ze względu na historię rodzinną lub osobistą historię zdrowotną powinny skonsultować się z lekarzem w celu omówienia czynników ryzyka i ewentualnych obaw zdrowotnych.¹⁷

W przypadkach wyjątkowo wysokiego ryzyka, lekarz może zdecydować o profilaktycznym usunięciu organu, takiego jak tarczyca, aby zapobiec rozwojowi guza neuroendokrynnego.¹⁸ Niektóre typy nowotworów i wzorce ich występowania w rodzinie mogą wskazywać na potrzebę rozważenia badań genetycznych w celu ustalenia, czy istnieje zwiększone ryzyko zachorowania na nowotwór.¹⁹

Rola diety w profilaktyce i leczeniu guzów neuroendokrynnych

Dieta odgrywa kluczową rolę w rozwoju, progresji i wynikach leczenia nowotworów. Spożywanie zdrowej żywności i składników odżywczych jest uważane za skuteczną strategię pierwotnej profilaktyki nowotworów, szczególnie nowotworów przewodu pokarmowego.²⁰ Szacuje się, że zmiany nawyków żywieniowych mogą przyczynić się do uniknięcia wystąpienia nowotworów w 30-50% przypadków.²¹

Dieta śródziemnomorska

Korzystne efekty diety śródziemnomorskiej (MD) są związane z wysoką zawartością polifenoli, witamin, flawonoidów i przeciwutleniaczy zawartych w żywności charakterystycznej dla tej diety.²² Badania wykazały, że dieta ta może zmniejszać ryzyko niektórych nowotworów, na przykład ryzyko raka prostaty zmniejszyło się nawet o 78% u osób z najwyższymi wynikami adherencji do diety śródziemnomorskiej, przy czym odnotowano spadek o 14% dla każdego jednego punktu wzrostu w skali adherencji do MD.²³

Dieta ketogeniczna i przemienny post

Dieta ketogeniczna (KD) wykazała obiecujące wyniki jako terapia wspomagająca w leczeniu nowotworów, głównie poprzez oddziaływanie na metabolizm guza, modulację ekspresji genów i mikrośrodowisko guza.²⁴ Może ona również poprawiać stan insulinooporności, nawet przed utratą masy ciała.²⁵

Przemienny post (IF) wykazuje obiecujące efekty przeciwnowotworowe w badaniach przedklinicznych, chociaż do tej pory nie przeprowadzono badań z udziałem pacjentów z NET.²⁶ Można jednak przypuszczać, że działanie przeciwzapalne i redukcja nadwagi i otyłości związane z IF mogłyby również poprawić odpowiedź guza na leczenie przeciwnowotworowe u pacjentów z NET.²⁷

Zalecenia żywieniowe dla pacjentów z NET

U pacjentów z zespołem rakowiaka (CS) zaleca się spożywanie małych i częstych posiłków.²⁸ Głównymi celami terapii żywieniowej dla pacjentów z nowotworami są zapobieganie niedożywieniu i utrzymanie zdrowej masy ciała, pomoc w zarządzaniu objawami oraz zmniejszenie ryzyka nietolerancji leczenia.²⁹

Plany żywieniowe stanowią integralną część multidyscyplinarnego zespołu leczącego pacjentów z guzami neuroendokrynnymi, ponieważ pozwalają na poprawę jakości życia.³⁰ Ocena żywieniowa oparta na składzie ciała i modyfikacje stylu życia powinny być integralną częścią leczenia pacjentów z NET.³¹ Zaleca się, aby ocena i postępowanie żywieniowe były przeprowadzane przez akredytowanego dietetyka.³²

Profilaktyka powikłań związanych z guzami neuroendokrynnymi

Zapobieganie przełomowi karcynoidalnemu

Pacjenci z zespołem rakowiaka powinni otrzymać profilaktykę oktreotydową w celu zapobieżenia rozwojowi przełomu karcynoidalnego podczas zabiegu chirurgicznego.³³ Jeśli pacjenci już otrzymują oktreotyd lub inne analogi somatostatyny, leczenie to powinno być kontynuowane w oczekiwaniu na zabieg chirurgiczny.³⁴

Pacjentom, którzy wcześniej nie otrzymywali oktreotydu, można podawać 100-200 μg 3 razy dziennie podskórnie przez 2 tygodnie przed zabiegiem.³⁵ Jeśli potrzebna jest bardziej nagła operacja, oktreotyd jest podawany w infuzji dożylnej przez 1-2 dni przed zabiegiem.³⁶

Aby zapobiec przełomowi karcynoidalnemu, należy podać profilaktycznie dożylny oktreotyd przed zabiegami inwazyjnymi. Oktreotyd powinien być rozcieńczony w soli fizjologicznej i podawany w dawce 1000 μg przez 24 godziny. Należy rozpocząć podawanie 12 godzin przed i kontynuować przez 24 do 48 godzin po zabiegu. Czas i dostosowanie dawek dożylnego oktreotydu zależy od rodzaju zabiegu i nasilenia zespołu rakowiaka u pacjenta.³⁷

W niektórych przypadkach możliwa jest profilaktyka małymi dawkami oktreotydu podawanymi podskórnie. W przypadku drobnych zabiegów, takich jak zabiegi stomatologiczne i leczenie wrastających paznokci, profilaktyka nie jest potrzebna.³⁸

Leczenie okołooperacyjne

Zaleca się leczenie okołooperacyjne dożylną infuzją oktreotydu, którą rozpoczyna się 12 godzin przed znieczuleniem w dawce 50-100 μg/h, stosując miareczkowanie dawki aż do ustąpienia objawów (średnia dawka 100-200 μg/h).³⁹

W przypadku reakcji przełomu karcynoidalnego z niedociśnieniem podczas znieczulenia, leki adrenergiczne należy stosować ostrożnie, a infuzję oktreotydu należy kontynuować nawet w dawkach tak wysokich jak 500 μg/h.⁴⁰ Pacjenci wcześniej leczeni analogami somatostatyny mogą wymagać jeszcze wyższych dawek.⁴¹

Profilaktyka zakrzepicy żylnej

Zakrzepica żylna występuje z dużą częstością po operacjach nowotworów jamy brzusznej, dlatego zaleca się 4-tygodniową profilaktykę przeciwzakrzepową po operacji.⁴² Rutynowa przedłużona profilaktyka przeciwzakrzepowa po operacji może być konieczna w przypadku guzów neuroendokrynnych trzustki (PNET), ale prawdopodobnie niepotrzebna w przypadku innych guzów neuroendokrynnych jamy brzusznej. Jednak klinicyści powinni brać pod uwagę czynniki ryzyka zidentyfikowane w badaniach przy rozważaniu rezygnacji z przedłużonej profilaktyki przeciwzakrzepowej u pacjentów z NET.⁴³

Profilaktyka reaktywacji guza po leczeniu

Krótkotrwała profilaktyka kortykosteroidowa w celu zapobieżenia reakcji zaostrzenia nowotworu u pacjentów wysokiego ryzyka z guzami neuroendokrynnymi leczonych 177Lu-DOTATATE nie wydaje się zmniejszać częstości występowania reakcji zaostrzenia nowotworu w porównaniu z wcześniej zgłaszanymi wynikami.⁴⁴ Potrzebne są randomizowane, kontrolowane placebo badania dotyczące stosowania kortykosteroidów w celu zapobiegania reakcji zaostrzenia nowotworu u pacjentów leczonych 177Lu-DOTATATE, aby w pełni wyjaśnić bezpieczeństwo i skuteczność kortykosteroidów stosowanych w tym kontekście.⁴⁵

Badania nad profilatyką guzów neuroendokrynnych

Obecnie prowadzone są badania mające na celu lepsze zrozumienie roli stylu życia w rozwoju guzów neuroendokrynnych.⁴⁶ Zakłada się, że styl życia odgrywa rolę w rozwoju NET, ale nie wiadomo, w jakim stopniu.⁴⁷ Poprzez te badania naukowcy mają nadzieję uzyskać wiedzę na temat roli, jaką styl życia odgrywa w tym typie raka i przyczynić się do opracowania środków zapobiegawczych w celu zmniejszenia ryzyka zachorowania na raka.⁴⁸

Niektóre ośrodki medyczne, takie jak Holden Comprehensive Cancer Center, są uznawane za jedne z wiodących światowych centrów badań nad NET. W 2015 roku naukowcy z Holden otrzymali grant SPORE (Specialized Programs of Research Excellence) w wysokości 10,67 miliona dolarów na badania nad zapobieganiem, wykrywaniem, diagnozowaniem i leczeniem NET. Jest to jedyny grant SPORE, jaki kiedykolwiek przyznano na badania nad NET.⁴⁹

Podsumowanie zaleceń profilaktycznych

Choć nie istnieją specyficzne metody zapobiegania guzom neuroendokrynnym ze względu na niejasną etiologię, wczesna identyfikacja guza może poprawić rokowanie pacjenta.⁵⁰ Dlatego najlepiej, aby osoba skontaktowała się z lekarzem, gdy tylko pojawią się obawy zdrowotne.⁵¹

Populacyjne zalecenia profilaktyczne obejmują:

Unikanie wyrobów tytoniowych⁵²⁵³
Ograniczenie spożycia alkoholu⁵⁴⁵⁵
Utrzymywanie prawidłowej masy ciała⁵⁶
Regularna aktywność fizyczna⁵⁷⁵⁸
Dieta bogata w owoce i warzywa, a uboga w przetworzone mięso⁵⁹
Regularne badania przesiewowe zalecane przez lekarza podstawowej opieki zdrowotnej⁶⁰

Osoby z predyspozycjami genetycznymi lub rodzinną historią guzów neuroendokrynnych powinny być pod szczególną obserwacją lekarską i rozważyć badania genetyczne w celu określenia indywidualnego ryzyka.⁶¹⁶²

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

Materiały źródłowe

#1 Neuroendocrine Tumors | MedStar Health
https://www.medstarhealth.org/services/neuroendocrine-tumors
We don’t know the exact cause of neuroendocrine tumors. Therefore, you can’t prevent this type of cancer. […] Neuroendocrine tumors (NETs) are a broad category of abnormal growths that begin in neuroendocrine cells, which are similar to nerve cells and hormone-producing cells. These tumors often produce abnormal amounts of hormones, affecting how the nervous system works.
#2
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#3 Neuroendocrine tumours | Cancer Council
https://www.cancer.org.au/cancer-information/types-of-cancer/rare-cancers/neuroendocrine-tumours
As the causes of most neuroendocrine tumours are not understood there is no prevention advice specific to this disease. […] Neuroendocrine tumours can be difficult to find and are sometimes diagnosed when patients are undergoing tests for a different condition.
#4 Neuroendocrine Tumors Risk Factors and Prevention | Banner Health
https://www.bannerhealth.com/services/cancer/cancer-type/neuroendocrine-tumors/risk-factors-and-prevention
Understanding your risk for neuroendocrine tumors is the first step in prevention and early diagnosis. […] Because there are no known controllable risk factors for neuroendocrine tumors, there is no way to prevent them. If you are at elevated risk for neuroendocrine tumors based on your family or personal health history, make an appointment with your doctor to discuss your risk factors and any health concerns you may have.
#5 Neuroendocrine Tumors (NETs): Symptoms & Treatment
https://my.clevelandclinic.org/health/diseases/22006-neuroendocrine-tumors-net
Can I prevent neuroendocrine tumors? As researchers dont know what causes NETs, theres nothing you can do to prevent them. Still, you can understand potential risk factors, like having an inherited condition like multiple endocrine neoplasia (MEN). […] Ask your healthcare provider for help understanding whether your family health history puts you at risk of developing NETs.
#6
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#7 Neuroendocrine tumors | UK Healthcare
https://ukhealthcare.uky.edu/markey-cancer-center/cancer-types/neuroendocrine
You can lower your risk of cancer by taking steps to build a healthy lifestyle. Here are some ways you can lower your risk for this disease, as well as improve your overall basic health: […] Avoid using tobacco products. Tobacco has been tied to multiple cancers, and it is responsible for 90 percent of lung cancer deaths. […] Stay physically active. Your physical activity is related to risk for colon and breast cancer. Excess weight gained from inactivity increases the risk of multiple cancers. […] Limit alcohol consumption. It is important to be mindful of how much alcohol you drink. Alcohol intake, even in moderate amounts, can increase the risk for colon, breast, esophageal and oropharyngeal cancer. […] Learn about screenings. Your primary care doctor can recommend appropriate cancer screenings based on your age, personal risk and family history.
#8
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#9 Neuroendocrine tumors | UK Healthcare
https://ukhealthcare.uky.edu/markey-cancer-center/cancer-types/neuroendocrine
You can lower your risk of cancer by taking steps to build a healthy lifestyle. Here are some ways you can lower your risk for this disease, as well as improve your overall basic health: […] Avoid using tobacco products. Tobacco has been tied to multiple cancers, and it is responsible for 90 percent of lung cancer deaths. […] Stay physically active. Your physical activity is related to risk for colon and breast cancer. Excess weight gained from inactivity increases the risk of multiple cancers. […] Limit alcohol consumption. It is important to be mindful of how much alcohol you drink. Alcohol intake, even in moderate amounts, can increase the risk for colon, breast, esophageal and oropharyngeal cancer. […] Learn about screenings. Your primary care doctor can recommend appropriate cancer screenings based on your age, personal risk and family history.
#10
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#11
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#12 Neuroendocrine tumors | UK Healthcare
https://ukhealthcare.uky.edu/markey-cancer-center/cancer-types/neuroendocrine
You can lower your risk of cancer by taking steps to build a healthy lifestyle. Here are some ways you can lower your risk for this disease, as well as improve your overall basic health: […] Avoid using tobacco products. Tobacco has been tied to multiple cancers, and it is responsible for 90 percent of lung cancer deaths. […] Stay physically active. Your physical activity is related to risk for colon and breast cancer. Excess weight gained from inactivity increases the risk of multiple cancers. […] Limit alcohol consumption. It is important to be mindful of how much alcohol you drink. Alcohol intake, even in moderate amounts, can increase the risk for colon, breast, esophageal and oropharyngeal cancer. […] Learn about screenings. Your primary care doctor can recommend appropriate cancer screenings based on your age, personal risk and family history.
#13
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#14 Can Pancreatic Neuroendocrine Tumor Be Prevented? | American Cancer Society
https://www.cancer.org/cancer/types/pancreatic-neuroendocrine-tumor/causes-risks-prevention/prevention.html
There is no sure way to prevent pancreatic neuroendocrine tumors (PNETs). Some risk factors, such as family history, cant be controlled. But there are things you can do that might lower your risk. […] Smoking is an avoidable risk factor for pNET. Quitting smoking may help lower risk. […] Heavy alcohol use has been tied to pNETs in some studies but not in others. This link has still not been proven, but heavy alcohol use can lead to conditions such as chronic pancreatitis, which has been associated with an increased risk of pNET.
#15 Can Pancreatic Neuroendocrine Tumor Be Prevented? | American Cancer Society
https://www.cancer.org/cancer/types/pancreatic-neuroendocrine-tumor/causes-risks-prevention/prevention.html
There is no sure way to prevent pancreatic neuroendocrine tumors (PNETs). Some risk factors, such as family history, cant be controlled. But there are things you can do that might lower your risk. […] Smoking is an avoidable risk factor for pNET. Quitting smoking may help lower risk. […] Heavy alcohol use has been tied to pNETs in some studies but not in others. This link has still not been proven, but heavy alcohol use can lead to conditions such as chronic pancreatitis, which has been associated with an increased risk of pNET.
#16 Neuroendocrine Tumors (NETs): Symptoms & Treatment
https://my.clevelandclinic.org/health/diseases/22006-neuroendocrine-tumors-net
Can I prevent neuroendocrine tumors? As researchers dont know what causes NETs, theres nothing you can do to prevent them. Still, you can understand potential risk factors, like having an inherited condition like multiple endocrine neoplasia (MEN). […] Ask your healthcare provider for help understanding whether your family health history puts you at risk of developing NETs.
#17 Neuroendocrine Tumors Risk Factors and Prevention | Banner Health
https://www.bannerhealth.com/services/cancer/cancer-type/neuroendocrine-tumors/risk-factors-and-prevention
Understanding your risk for neuroendocrine tumors is the first step in prevention and early diagnosis. […] Because there are no known controllable risk factors for neuroendocrine tumors, there is no way to prevent them. If you are at elevated risk for neuroendocrine tumors based on your family or personal health history, make an appointment with your doctor to discuss your risk factors and any health concerns you may have.
#18 Preventing and Detecting Neuroendocrine Tumors | Roswell Park Comprehensive Cancer Center – Buffalo, NY
https://www.roswellpark.org/cancer/neuroendocrine-tumors/prevention-detection
The cause of neuroendocrine tumors remains unclear, and so strategies to prevent the disease are difficult to conclude. However, certain known genetic and medical conditions are associated with several cancer types, including NETs. These include: […] If you have one of these risk factors, your doctor may watch you closely. If your risk appears to be extremely high, your doctor may choose to remove an organ, such as the thyroid, to prevent a neuroendocrine tumor from growing there. Its important to know your familys cancer history and discuss it with your doctor. Certain cancer types and patterns of cancer in your family may indicate you should consider genetic screening to learn whether you have an increased risk for cancer. […] Understanding how a cancer begins and grows is an important first step toward fighting and preventing it.
#19 Preventing and Detecting Neuroendocrine Tumors | Roswell Park Comprehensive Cancer Center – Buffalo, NY
https://www.roswellpark.org/cancer/neuroendocrine-tumors/prevention-detection
The cause of neuroendocrine tumors remains unclear, and so strategies to prevent the disease are difficult to conclude. However, certain known genetic and medical conditions are associated with several cancer types, including NETs. These include: […] If you have one of these risk factors, your doctor may watch you closely. If your risk appears to be extremely high, your doctor may choose to remove an organ, such as the thyroid, to prevent a neuroendocrine tumor from growing there. Its important to know your familys cancer history and discuss it with your doctor. Certain cancer types and patterns of cancer in your family may indicate you should consider genetic screening to learn whether you have an increased risk for cancer. […] Understanding how a cancer begins and grows is an important first step toward fighting and preventing it.
#20 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
The crucial role of diet in the development, progression, and outcome of cancer is well known, and the consumption of healthy foods and nutrients is considered an effective strategy for primary cancer prevention, especially in gastrointestinal neoplasms, while tailoring the diet in the disease phase is the key to coping with the symptoms that cancer brings. […] Based on this potential, several dietary patterns for patients with cancer are currently being studied. […] It is estimated that changes in alimentary habits can contribute to avoid cancer onset of 30â50%. […] The beneficial effects of MD are related to the high content of polyphenol, vitamins, flavonoids, and antioxidants contained in Mediterranean foods. […] Overall, these assumptions together with the well-known relationship between obesity and cancer risk have paved the way to study the association of cancers incidence and mortality with adherence to MD.
#21 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
The crucial role of diet in the development, progression, and outcome of cancer is well known, and the consumption of healthy foods and nutrients is considered an effective strategy for primary cancer prevention, especially in gastrointestinal neoplasms, while tailoring the diet in the disease phase is the key to coping with the symptoms that cancer brings. […] Based on this potential, several dietary patterns for patients with cancer are currently being studied. […] It is estimated that changes in alimentary habits can contribute to avoid cancer onset of 30â50%. […] The beneficial effects of MD are related to the high content of polyphenol, vitamins, flavonoids, and antioxidants contained in Mediterranean foods. […] Overall, these assumptions together with the well-known relationship between obesity and cancer risk have paved the way to study the association of cancers incidence and mortality with adherence to MD.
#22 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
The crucial role of diet in the development, progression, and outcome of cancer is well known, and the consumption of healthy foods and nutrients is considered an effective strategy for primary cancer prevention, especially in gastrointestinal neoplasms, while tailoring the diet in the disease phase is the key to coping with the symptoms that cancer brings. […] Based on this potential, several dietary patterns for patients with cancer are currently being studied. […] It is estimated that changes in alimentary habits can contribute to avoid cancer onset of 30â50%. […] The beneficial effects of MD are related to the high content of polyphenol, vitamins, flavonoids, and antioxidants contained in Mediterranean foods. […] Overall, these assumptions together with the well-known relationship between obesity and cancer risk have paved the way to study the association of cancers incidence and mortality with adherence to MD.
#23 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
The predictive capacity of MD in the evaluation of the risk did not change, even when employing different MD scores, such as the Italian Mediterranean Index, mMDS, and center-specific mMDS (CSmMDS), or considering confounding variables. […] Therefore, prostate cancer risk decreased until 78% in subjects with the highest MD scores, registering in particular a decrease of 14% for each one-point increase in MD score. […] In patients with CS, small and frequent meals should be suggested. […] KD regimen showed promising results as an adjuvant cancer therapy, mainly targeting tumor metabolism, through the modulation of gene expression, as well as tumor microenvironment. […] This hypothesis leads us to speculate that KD can improve the condition of insulin resistance, even before weight loss.
#24 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
The predictive capacity of MD in the evaluation of the risk did not change, even when employing different MD scores, such as the Italian Mediterranean Index, mMDS, and center-specific mMDS (CSmMDS), or considering confounding variables. […] Therefore, prostate cancer risk decreased until 78% in subjects with the highest MD scores, registering in particular a decrease of 14% for each one-point increase in MD score. […] In patients with CS, small and frequent meals should be suggested. […] KD regimen showed promising results as an adjuvant cancer therapy, mainly targeting tumor metabolism, through the modulation of gene expression, as well as tumor microenvironment. […] This hypothesis leads us to speculate that KD can improve the condition of insulin resistance, even before weight loss.
#25 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
The predictive capacity of MD in the evaluation of the risk did not change, even when employing different MD scores, such as the Italian Mediterranean Index, mMDS, and center-specific mMDS (CSmMDS), or considering confounding variables. […] Therefore, prostate cancer risk decreased until 78% in subjects with the highest MD scores, registering in particular a decrease of 14% for each one-point increase in MD score. […] In patients with CS, small and frequent meals should be suggested. […] KD regimen showed promising results as an adjuvant cancer therapy, mainly targeting tumor metabolism, through the modulation of gene expression, as well as tumor microenvironment. […] This hypothesis leads us to speculate that KD can improve the condition of insulin resistance, even before weight loss.
#26 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
Even if preclinical studies showed the promising effects of IF on cancer, to date, no studies conducted in NET patients are available. […] However, based on studies in non-cancer patients, we can only speculate that the anti-inflammatory effects and overweight and obesity reduction related to IF could also improve the tumor responses to anticancer treatment in NET patients. […] The main goals of nutritional therapy for cancer patients are to prevent malnutrition and maintain a healthy weight, assist in symptom management, and reduce risk of treatment intolerance. […] For these reasons, nutrition assessment and management should be an integral part of the management of patients with NETs and should be performed by an accredited dietitian.
#27 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
Even if preclinical studies showed the promising effects of IF on cancer, to date, no studies conducted in NET patients are available. […] However, based on studies in non-cancer patients, we can only speculate that the anti-inflammatory effects and overweight and obesity reduction related to IF could also improve the tumor responses to anticancer treatment in NET patients. […] The main goals of nutritional therapy for cancer patients are to prevent malnutrition and maintain a healthy weight, assist in symptom management, and reduce risk of treatment intolerance. […] For these reasons, nutrition assessment and management should be an integral part of the management of patients with NETs and should be performed by an accredited dietitian.
#28 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
The predictive capacity of MD in the evaluation of the risk did not change, even when employing different MD scores, such as the Italian Mediterranean Index, mMDS, and center-specific mMDS (CSmMDS), or considering confounding variables. […] Therefore, prostate cancer risk decreased until 78% in subjects with the highest MD scores, registering in particular a decrease of 14% for each one-point increase in MD score. […] In patients with CS, small and frequent meals should be suggested. […] KD regimen showed promising results as an adjuvant cancer therapy, mainly targeting tumor metabolism, through the modulation of gene expression, as well as tumor microenvironment. […] This hypothesis leads us to speculate that KD can improve the condition of insulin resistance, even before weight loss.
#29 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
Even if preclinical studies showed the promising effects of IF on cancer, to date, no studies conducted in NET patients are available. […] However, based on studies in non-cancer patients, we can only speculate that the anti-inflammatory effects and overweight and obesity reduction related to IF could also improve the tumor responses to anticancer treatment in NET patients. […] The main goals of nutritional therapy for cancer patients are to prevent malnutrition and maintain a healthy weight, assist in symptom management, and reduce risk of treatment intolerance. […] For these reasons, nutrition assessment and management should be an integral part of the management of patients with NETs and should be performed by an accredited dietitian.
#30 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
Neuroendocrine neoplasms and their main subtype neuroendocrine tumors have an increasing incidence worldwide, associated with a high survival and prevalence rate. […] The aim of this review is to condense the latest evidence on the role of the most widely used dietary patterns, the Mediterranean diet, the ketogenic diet and intermittent fasting, in the context of neuroendocrine tumors. Nutritional plans are an integral part of the multidisciplinary treatment team of patients with neuroendocrine tumors because they improve the patientâs quality of life. […] Therefore, dietary assessment based on body composition and lifestyle modifications should be an integral part of the treatment of NET patients. Nutrition plans are an integral part of the multidisciplinary treatment team for patients with NETs because they allow an improvement in the quality of life, providing a tailored approach based on nutritional needs and nutritional manageable signs and/or symptoms related to pharmacological treatment.
#31 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
Neuroendocrine neoplasms and their main subtype neuroendocrine tumors have an increasing incidence worldwide, associated with a high survival and prevalence rate. […] The aim of this review is to condense the latest evidence on the role of the most widely used dietary patterns, the Mediterranean diet, the ketogenic diet and intermittent fasting, in the context of neuroendocrine tumors. Nutritional plans are an integral part of the multidisciplinary treatment team of patients with neuroendocrine tumors because they improve the patientâs quality of life. […] Therefore, dietary assessment based on body composition and lifestyle modifications should be an integral part of the treatment of NET patients. Nutrition plans are an integral part of the multidisciplinary treatment team for patients with NETs because they allow an improvement in the quality of life, providing a tailored approach based on nutritional needs and nutritional manageable signs and/or symptoms related to pharmacological treatment.
#32 Neuroendocrine Tumors: A Comprehensive Review on Nutritional Approaches
https://www.mdpi.com/2072-6694/14/18/4402
Even if preclinical studies showed the promising effects of IF on cancer, to date, no studies conducted in NET patients are available. […] However, based on studies in non-cancer patients, we can only speculate that the anti-inflammatory effects and overweight and obesity reduction related to IF could also improve the tumor responses to anticancer treatment in NET patients. […] The main goals of nutritional therapy for cancer patients are to prevent malnutrition and maintain a healthy weight, assist in symptom management, and reduce risk of treatment intolerance. […] For these reasons, nutrition assessment and management should be an integral part of the management of patients with NETs and should be performed by an accredited dietitian.
#33 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
https://pmc.ncbi.nlm.nih.gov/articles/PMC5637287/
Patients with carcinoid syndrome should receive octreotide prophylaxis to prevent the development of carcinoid crisis during surgery. […] If patients already receive octreotide or other somatostatin analogs, this medication should be continued while awaiting surgery. […] Patients who have not received octreotide can be given 100-200 g 3 times/day subcutaneously for 2 weeks prior to surgery. […] If more acute operation is needed, octreotide is given as an intravenous infusion for 1-2 days before surgery. […] Perioperative treatment is recommended with intravenous octreotide; infusion is started 12 h before anesthesia at a dose of 50-100 g/h using dose titration until resolution of the symptoms (mean dose 100-200 g/h). […] In case of a carcinoid crisis reaction with hypotension during anesthesia, adrenergic drugs should be used cautiously and further octreotide infusion should be given even at doses as high as 500 g/h. […] Patients previously treated with somatostatin analogs may require even higher doses.
#34 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
https://pmc.ncbi.nlm.nih.gov/articles/PMC5637287/
Patients with carcinoid syndrome should receive octreotide prophylaxis to prevent the development of carcinoid crisis during surgery. […] If patients already receive octreotide or other somatostatin analogs, this medication should be continued while awaiting surgery. […] Patients who have not received octreotide can be given 100-200 g 3 times/day subcutaneously for 2 weeks prior to surgery. […] If more acute operation is needed, octreotide is given as an intravenous infusion for 1-2 days before surgery. […] Perioperative treatment is recommended with intravenous octreotide; infusion is started 12 h before anesthesia at a dose of 50-100 g/h using dose titration until resolution of the symptoms (mean dose 100-200 g/h). […] In case of a carcinoid crisis reaction with hypotension during anesthesia, adrenergic drugs should be used cautiously and further octreotide infusion should be given even at doses as high as 500 g/h. […] Patients previously treated with somatostatin analogs may require even higher doses.
#35 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
https://pmc.ncbi.nlm.nih.gov/articles/PMC5637287/
Patients with carcinoid syndrome should receive octreotide prophylaxis to prevent the development of carcinoid crisis during surgery. […] If patients already receive octreotide or other somatostatin analogs, this medication should be continued while awaiting surgery. […] Patients who have not received octreotide can be given 100-200 g 3 times/day subcutaneously for 2 weeks prior to surgery. […] If more acute operation is needed, octreotide is given as an intravenous infusion for 1-2 days before surgery. […] Perioperative treatment is recommended with intravenous octreotide; infusion is started 12 h before anesthesia at a dose of 50-100 g/h using dose titration until resolution of the symptoms (mean dose 100-200 g/h). […] In case of a carcinoid crisis reaction with hypotension during anesthesia, adrenergic drugs should be used cautiously and further octreotide infusion should be given even at doses as high as 500 g/h. […] Patients previously treated with somatostatin analogs may require even higher doses.
#36 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
https://pmc.ncbi.nlm.nih.gov/articles/PMC5637287/
Patients with carcinoid syndrome should receive octreotide prophylaxis to prevent the development of carcinoid crisis during surgery. […] If patients already receive octreotide or other somatostatin analogs, this medication should be continued while awaiting surgery. […] Patients who have not received octreotide can be given 100-200 g 3 times/day subcutaneously for 2 weeks prior to surgery. […] If more acute operation is needed, octreotide is given as an intravenous infusion for 1-2 days before surgery. […] Perioperative treatment is recommended with intravenous octreotide; infusion is started 12 h before anesthesia at a dose of 50-100 g/h using dose titration until resolution of the symptoms (mean dose 100-200 g/h). […] In case of a carcinoid crisis reaction with hypotension during anesthesia, adrenergic drugs should be used cautiously and further octreotide infusion should be given even at doses as high as 500 g/h. […] Patients previously treated with somatostatin analogs may require even higher doses.
#37 Prevention and Management of Carcinoid Crisis – Neuroendocrine Cancer Irish Patient Support Group
https://neuroendocrinecancer.ie/prevention-and-management-of-carcinoid-crisis/
To prevent the carcinoid crisis, prophylactic intravenous octreotide should be administered prior to invasive procedures. The octreotide should be diluted in normal saline and given in a dose of 1000 mcg over 24 hours. It should be started 12 hours before, and continue for 24 to 48 hours after the procedure. Timing and dose adjustments of intravenous octreotide doses depend on the procedure type and the severity of the patients carcinoid syndrome. […] In some cases, prophylaxis with small subcutaneous octreotide doses is possible. In minor procedures, for example dental procedures and ingrown toenails, prophylaxis is not needed.
#38 Prevention and Management of Carcinoid Crisis – Neuroendocrine Cancer Irish Patient Support Group
https://neuroendocrinecancer.ie/prevention-and-management-of-carcinoid-crisis/
To prevent the carcinoid crisis, prophylactic intravenous octreotide should be administered prior to invasive procedures. The octreotide should be diluted in normal saline and given in a dose of 1000 mcg over 24 hours. It should be started 12 hours before, and continue for 24 to 48 hours after the procedure. Timing and dose adjustments of intravenous octreotide doses depend on the procedure type and the severity of the patients carcinoid syndrome. […] In some cases, prophylaxis with small subcutaneous octreotide doses is possible. In minor procedures, for example dental procedures and ingrown toenails, prophylaxis is not needed.
#39 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
https://pmc.ncbi.nlm.nih.gov/articles/PMC5637287/
Patients with carcinoid syndrome should receive octreotide prophylaxis to prevent the development of carcinoid crisis during surgery. […] If patients already receive octreotide or other somatostatin analogs, this medication should be continued while awaiting surgery. […] Patients who have not received octreotide can be given 100-200 g 3 times/day subcutaneously for 2 weeks prior to surgery. […] If more acute operation is needed, octreotide is given as an intravenous infusion for 1-2 days before surgery. […] Perioperative treatment is recommended with intravenous octreotide; infusion is started 12 h before anesthesia at a dose of 50-100 g/h using dose titration until resolution of the symptoms (mean dose 100-200 g/h). […] In case of a carcinoid crisis reaction with hypotension during anesthesia, adrenergic drugs should be used cautiously and further octreotide infusion should be given even at doses as high as 500 g/h. […] Patients previously treated with somatostatin analogs may require even higher doses.
#40 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
https://pmc.ncbi.nlm.nih.gov/articles/PMC5637287/
Patients with carcinoid syndrome should receive octreotide prophylaxis to prevent the development of carcinoid crisis during surgery. […] If patients already receive octreotide or other somatostatin analogs, this medication should be continued while awaiting surgery. […] Patients who have not received octreotide can be given 100-200 g 3 times/day subcutaneously for 2 weeks prior to surgery. […] If more acute operation is needed, octreotide is given as an intravenous infusion for 1-2 days before surgery. […] Perioperative treatment is recommended with intravenous octreotide; infusion is started 12 h before anesthesia at a dose of 50-100 g/h using dose titration until resolution of the symptoms (mean dose 100-200 g/h). […] In case of a carcinoid crisis reaction with hypotension during anesthesia, adrenergic drugs should be used cautiously and further octreotide infusion should be given even at doses as high as 500 g/h. […] Patients previously treated with somatostatin analogs may require even higher doses.
#41 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
https://pmc.ncbi.nlm.nih.gov/articles/PMC5637287/
Patients with carcinoid syndrome should receive octreotide prophylaxis to prevent the development of carcinoid crisis during surgery. […] If patients already receive octreotide or other somatostatin analogs, this medication should be continued while awaiting surgery. […] Patients who have not received octreotide can be given 100-200 g 3 times/day subcutaneously for 2 weeks prior to surgery. […] If more acute operation is needed, octreotide is given as an intravenous infusion for 1-2 days before surgery. […] Perioperative treatment is recommended with intravenous octreotide; infusion is started 12 h before anesthesia at a dose of 50-100 g/h using dose titration until resolution of the symptoms (mean dose 100-200 g/h). […] In case of a carcinoid crisis reaction with hypotension during anesthesia, adrenergic drugs should be used cautiously and further octreotide infusion should be given even at doses as high as 500 g/h. […] Patients previously treated with somatostatin analogs may require even higher doses.
#42 Do All Abdominal Neuroendocrine Tumors Require Extended Postoperative VTE Prophylaxis? A NSQIP Analysis – PubMed
https://pubmed.ncbi.nlm.nih.gov/30671795/
Venous thromboembolism (VTE) occurs at high incidence in abdominal cancer surgery; therefore, a 4-week postoperative VTE prophylaxis is advocated. […] Routine extended VTE prophylaxis after surgery may be necessary in PNETs, but probably unnecessary in other abdominal NETs. However, clinicians should use risk factors identified in this study when considering to forego extended VTE prophylaxis in NET patients.
#43 Do All Abdominal Neuroendocrine Tumors Require Extended Postoperative VTE Prophylaxis? A NSQIP Analysis – PubMed
https://pubmed.ncbi.nlm.nih.gov/30671795/
Venous thromboembolism (VTE) occurs at high incidence in abdominal cancer surgery; therefore, a 4-week postoperative VTE prophylaxis is advocated. […] Routine extended VTE prophylaxis after surgery may be necessary in PNETs, but probably unnecessary in other abdominal NETs. However, clinicians should use risk factors identified in this study when considering to forego extended VTE prophylaxis in NET patients.
#44 Corticosteroid prophylaxis did not decrease tumor flare reaction in high-risk neuroendocrine tumors patients treated with 177Lu-DOTATATE | NANETS2024 | NANETS 2024 | Endocrine Abstracts
https://www.endocrine-abstracts.org/ea/0108/ea0108c33
Corticosteroid prophylaxis did not decrease tumor flare reaction in high-risk neuroendocrine tumors patients treated with 177Lu-DOTATATE. […] Short-course corticosteroid prophylaxis to prevent tumor flare reaction in high-risk patients with neuroendocrine tumors treated with 177Lu-DOTATATE did not appear to decrease the incidence of tumor flare reactions compared to previously reported numbers. […] Randomized, placebo-controlled trials looking at the use of corticosteroids to prevent tumor flare reaction in patients treated with 177Lu-DOTATATE are needed to fully elucidate the safety and efficacy of corticosteroids used in this setting.
#45 Corticosteroid prophylaxis did not decrease tumor flare reaction in high-risk neuroendocrine tumors patients treated with 177Lu-DOTATATE | NANETS2024 | NANETS 2024 | Endocrine Abstracts
https://www.endocrine-abstracts.org/ea/0108/ea0108c33
Corticosteroid prophylaxis did not decrease tumor flare reaction in high-risk neuroendocrine tumors patients treated with 177Lu-DOTATATE. […] Short-course corticosteroid prophylaxis to prevent tumor flare reaction in high-risk patients with neuroendocrine tumors treated with 177Lu-DOTATATE did not appear to decrease the incidence of tumor flare reactions compared to previously reported numbers. […] Randomized, placebo-controlled trials looking at the use of corticosteroids to prevent tumor flare reaction in patients treated with 177Lu-DOTATATE are needed to fully elucidate the safety and efficacy of corticosteroids used in this setting.
#46 Investigating the role of lifestyle in neuroendocrine tumours | World Cancer Research Fund
https://www.wcrf.org/research-policy/our-research/grants-database/investigating-the-role-of-lifestyle-in-neuroendocrine-tumours/
Neuroendocrine tumors are rare tumors that come from hormone-producing cells in the body. This study aims to investigate the relationship between lifestyle and the development of these tumours. […] Over the past years, it has been established that lifestyle in general plays an important role in cancer, with up to half of all cancers thought to be related to lifestyle. […] We assume that lifestyle plays a role in the development of NETs, but we do not know to what extent. […] Through this research, we hope to gain knowledge of the role lifestyle plays in this type of cancer and contribute to preventive measures to reduce the risk of cancer.
#47 Investigating the role of lifestyle in neuroendocrine tumours | World Cancer Research Fund
https://www.wcrf.org/research-policy/our-research/grants-database/investigating-the-role-of-lifestyle-in-neuroendocrine-tumours/
Neuroendocrine tumors are rare tumors that come from hormone-producing cells in the body. This study aims to investigate the relationship between lifestyle and the development of these tumours. […] Over the past years, it has been established that lifestyle in general plays an important role in cancer, with up to half of all cancers thought to be related to lifestyle. […] We assume that lifestyle plays a role in the development of NETs, but we do not know to what extent. […] Through this research, we hope to gain knowledge of the role lifestyle plays in this type of cancer and contribute to preventive measures to reduce the risk of cancer.
#48 Investigating the role of lifestyle in neuroendocrine tumours | World Cancer Research Fund
https://www.wcrf.org/research-policy/our-research/grants-database/investigating-the-role-of-lifestyle-in-neuroendocrine-tumours/
Neuroendocrine tumors are rare tumors that come from hormone-producing cells in the body. This study aims to investigate the relationship between lifestyle and the development of these tumours. […] Over the past years, it has been established that lifestyle in general plays an important role in cancer, with up to half of all cancers thought to be related to lifestyle. […] We assume that lifestyle plays a role in the development of NETs, but we do not know to what extent. […] Through this research, we hope to gain knowledge of the role lifestyle plays in this type of cancer and contribute to preventive measures to reduce the risk of cancer.
#49 Neuroendocrine tumor program earns high European distinction. | Holden
https://cancer.uiowa.edu/news/neuroendocrine-tumor-program-earns-high-european-distinction
Holden is already recognized as one of the worlds leading NET research centers. In 2015, Holden researchers received a $10.67 million Specialized Programs of Research Excellence (SPORE) grant to study the prevention, detection, diagnosis, and treatment of NETs. It is the only SPORE grant ever awarded for the study of NETs. […] UI pediatric oncologist M. Sue ODorisio, MD, PhD, who is the principal investigator of the NET SPORE, says the European Neuroendocrine Tumor Center of Excellence designation shows Holdens full commitment to NET care and prevention.
#50 Neuroendocrine tumor: Types, symptoms, causes, treatments
https://www.medicalnewstoday.com/articles/neuroendocrine-tumor
Is it possible to prevent a neuroendocrine tumor? As the exact cause of NETs is unclear, prevention may not be possible. However, early identification of the tumor may improve an individuals outlook. Therefore, it is best for a person to contact a doctor as soon as they have concerns.
#51 Neuroendocrine tumor: Types, symptoms, causes, treatments
https://www.medicalnewstoday.com/articles/neuroendocrine-tumor
Is it possible to prevent a neuroendocrine tumor? As the exact cause of NETs is unclear, prevention may not be possible. However, early identification of the tumor may improve an individuals outlook. Therefore, it is best for a person to contact a doctor as soon as they have concerns.
#52
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#53 Neuroendocrine tumors | UK Healthcare
https://ukhealthcare.uky.edu/markey-cancer-center/cancer-types/neuroendocrine
You can lower your risk of cancer by taking steps to build a healthy lifestyle. Here are some ways you can lower your risk for this disease, as well as improve your overall basic health: […] Avoid using tobacco products. Tobacco has been tied to multiple cancers, and it is responsible for 90 percent of lung cancer deaths. […] Stay physically active. Your physical activity is related to risk for colon and breast cancer. Excess weight gained from inactivity increases the risk of multiple cancers. […] Limit alcohol consumption. It is important to be mindful of how much alcohol you drink. Alcohol intake, even in moderate amounts, can increase the risk for colon, breast, esophageal and oropharyngeal cancer. […] Learn about screenings. Your primary care doctor can recommend appropriate cancer screenings based on your age, personal risk and family history.
#54
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#55 Neuroendocrine tumors | UK Healthcare
https://ukhealthcare.uky.edu/markey-cancer-center/cancer-types/neuroendocrine
You can lower your risk of cancer by taking steps to build a healthy lifestyle. Here are some ways you can lower your risk for this disease, as well as improve your overall basic health: […] Avoid using tobacco products. Tobacco has been tied to multiple cancers, and it is responsible for 90 percent of lung cancer deaths. […] Stay physically active. Your physical activity is related to risk for colon and breast cancer. Excess weight gained from inactivity increases the risk of multiple cancers. […] Limit alcohol consumption. It is important to be mindful of how much alcohol you drink. Alcohol intake, even in moderate amounts, can increase the risk for colon, breast, esophageal and oropharyngeal cancer. […] Learn about screenings. Your primary care doctor can recommend appropriate cancer screenings based on your age, personal risk and family history.
#56
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#57
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#58 Neuroendocrine tumors | UK Healthcare
https://ukhealthcare.uky.edu/markey-cancer-center/cancer-types/neuroendocrine
You can lower your risk of cancer by taking steps to build a healthy lifestyle. Here are some ways you can lower your risk for this disease, as well as improve your overall basic health: […] Avoid using tobacco products. Tobacco has been tied to multiple cancers, and it is responsible for 90 percent of lung cancer deaths. […] Stay physically active. Your physical activity is related to risk for colon and breast cancer. Excess weight gained from inactivity increases the risk of multiple cancers. […] Limit alcohol consumption. It is important to be mindful of how much alcohol you drink. Alcohol intake, even in moderate amounts, can increase the risk for colon, breast, esophageal and oropharyngeal cancer. […] Learn about screenings. Your primary care doctor can recommend appropriate cancer screenings based on your age, personal risk and family history.
#59
https://winshipcancer.emory.edu/cancer-types-and-treatments/neuroendocrine-tumors/prevention.php
While its unclear what causes neuroendocrine tumors, following neuroendocrine cancer prevention advice may help you lower your risk for the disease. […] While we dont know exactly what causes neuroendocrine cancer and therefore cant make specific suggestions on how to prevent it, its always a good idea to take steps to lower your overall risk of cancer through lifestyle modification. The following guidelines may be important for neuroendocrine cancer prevention. […] Not using any tobacco products […] Not drinking alcohol […] Maintaining a healthy body weight (e.g., body mass index below 25) […] Being physically active every day […] Eating a diet rich in fruits and vegetables and low in processed meats.
#60 Neuroendocrine tumors | UK Healthcare
https://ukhealthcare.uky.edu/markey-cancer-center/cancer-types/neuroendocrine
You can lower your risk of cancer by taking steps to build a healthy lifestyle. Here are some ways you can lower your risk for this disease, as well as improve your overall basic health: […] Avoid using tobacco products. Tobacco has been tied to multiple cancers, and it is responsible for 90 percent of lung cancer deaths. […] Stay physically active. Your physical activity is related to risk for colon and breast cancer. Excess weight gained from inactivity increases the risk of multiple cancers. […] Limit alcohol consumption. It is important to be mindful of how much alcohol you drink. Alcohol intake, even in moderate amounts, can increase the risk for colon, breast, esophageal and oropharyngeal cancer. […] Learn about screenings. Your primary care doctor can recommend appropriate cancer screenings based on your age, personal risk and family history.
#61 Preventing and Detecting Neuroendocrine Tumors | Roswell Park Comprehensive Cancer Center – Buffalo, NY
https://www.roswellpark.org/cancer/neuroendocrine-tumors/prevention-detection
The cause of neuroendocrine tumors remains unclear, and so strategies to prevent the disease are difficult to conclude. However, certain known genetic and medical conditions are associated with several cancer types, including NETs. These include: […] If you have one of these risk factors, your doctor may watch you closely. If your risk appears to be extremely high, your doctor may choose to remove an organ, such as the thyroid, to prevent a neuroendocrine tumor from growing there. Its important to know your familys cancer history and discuss it with your doctor. Certain cancer types and patterns of cancer in your family may indicate you should consider genetic screening to learn whether you have an increased risk for cancer. […] Understanding how a cancer begins and grows is an important first step toward fighting and preventing it.
#62 Neuroendocrine Tumors (NETs): Symptoms & Treatment
https://my.clevelandclinic.org/health/diseases/22006-neuroendocrine-tumors-net
Can I prevent neuroendocrine tumors? As researchers dont know what causes NETs, theres nothing you can do to prevent them. Still, you can understand potential risk factors, like having an inherited condition like multiple endocrine neoplasia (MEN). […] Ask your healthcare provider for help understanding whether your family health history puts you at risk of developing NETs.